In addition, HOTAIR expression as a negative prognostic predictor of poor outcomes in glioma patients raises the possibility of its potential utility as a biotarget for oncological therapies, particularly in gliomas (“HOTAIR-Based Diagnostic and Prognostic Biomarkers from Peripheral Samples” section). Here, HOTAIR is linked to glioma.